Nan Fung Group Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,815
| Closed | -$760K | – | 37 |
|
|
2024
Q3 | $760K | Hold |
10,815
| – | – | 0.65% | 26 |
|
|
2024
Q2 | $890K | Hold |
10,815
| – | – | 0.95% | 23 |
|
|
2024
Q1 | $945K | Buy |
10,815
+7,200
| +199% | +$629K | 0.88% | 25 |
|
|
2023
Q4 | $349K | Hold |
3,615
| – | – | 0.22% | 31 |
|
|
2023
Q3 | $320K | Hold |
3,615
| – | – | 0.26% | 30 |
|
|
2023
Q2 | $313K | Sell |
3,615
-3,600
| -50% | -$312K | 0.2% | 34 |
|
|
2023
Q1 | $702K | Buy |
7,215
+1,100
| +18% | +$107K | 0.48% | 25 |
|
|
2022
Q4 | $633K | Hold |
6,115
| – | – | 0.44% | 23 |
|
|
2022
Q3 | $518K | Hold |
6,115
| – | – | 0.33% | 25 |
|
|
2022
Q2 | $507K | Hold |
6,115
| – | – | 0.35% | 26 |
|
|
2022
Q1 | $471K | Sell |
6,115
-1,345
| -18% | -$104K | 0.22% | 32 |
|
|
2021
Q4 | $659K | Buy |
+7,460
| New | +$659K | 0.2% | 31 |
|